NEKTAR THERAPEUTICS (NKTR) Institutional Ownership
None of the superinvestors we track currently report NEKTAR THERAPEUTICS (NKTR) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in NEKTAR THERAPEUTICS (NKTR), this page will show institutional holding trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q1 2025 | 1 | $3,197,211 | 4,701,781 |
| Q4 2024 | 1 | $3,637,031 | 3,910,786 |
| Q3 2024 | 1 | $4,325,923 | 3,327,633 |
| Q2 2024 | 1 | $4,109,153 | 3,313,833 |
| Q1 2024 | 1 | $4,317 | 4,620,681 |
| Q4 2023 | 1 | $3,009 | 5,325,475 |
| Q3 2023 | 1 | $2,089 | 3,506,681 |
| Q2 2023 | 1 | $2,354 | 4,091,681 |
| Q1 2023 | 1 | $2,111 | 3,003,696 |
| Q4 2022 | 1 | $265 | 117,111 |
| Q2 2019 | 1 | $11,636 | 327,048 |
| Q1 2019 | 1 | $6,903 | 205,448 |
Related NKTR Institutional Insights:
- NKTR Institutional Ownership & Insiders Activity
- NKTR Institutional Ownership & 13F Activity
- NKTR Top Institutional Shareholders
- NKTR Institutional Buying Activity
- NKTR Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- NKTR Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings